K. Wright

J. M. Boss, K. Wright, G. Blanck, 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Cellular Differentiation Regulator BLIMP1 Induces Epstein-Barr Virus Lytic Reactivation in Epithelial and B Cells by Activating Transcription from both the R and Z Promoters

J. Mertz, K. Wright, S. Kenney, 2014, Journal of Virology.

A rat histone H4 gene closely associated with the testis-specific H1t gene.

G. Stein, K. Wright, J. Stein, 1987, Experimental cell research.

Constitutively Activated DAP12 Induces Functional Anti-Tumor Activation and Maturation of Human Monocyte-Derived DC

D. Gilvary, Sheng Wei, K. Wright, 2021, International journal of molecular sciences.

PRDM1/Blimp-1 Controls Effector Cytokine Production in Human NK Cells

M. Caligiuri, Sheng Wei, K. Wright, 2010, The Journal of Immunology.

Bipartite structure of the proximal promoter of a human H4 histone gene

G. Stein, K. Wright, A. V. van Wijnen, 1995, Journal of cellular biochemistry.

Functional role for Sp1 in the transcriptional amplification of a cell cycle regulated histone H4 gene.

B. Frenkel, K. Wright, A. V. van Wijnen, 1995, Biochemistry.

Signaling and Regulation Molecular Cancer Research PRDM 1 Is Required for Mantle Cell Lymphoma Response to Bortezomib

K. Wright, S. Desai, J. Tao, 2010 .

CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo.

G. Stark, J. M. Boss, K. Wright, 1998, Proceedings of the National Academy of Sciences of the United States of America.

CIITAMHC Class II Expression via IRF4 and Cell Activation of CD4 T Cells by Promoting Tuberous Sclerosis Complex 1 in Dendritic Critical Role of the Tumor Suppressor

K. Wright, G. Wright, Yang, 2013 .

PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing

K. Wright, E. Seto, G. Fejer, 2004, Nature Immunology.

Data supporting the functional role of Eleven-nineteen Lysine-rich Leukemia 3 (ELL3) in B cell lymphoma cell line cells

K. Wright, P. Murray, Brook S. Nepon-Sixt, 2017, Data in brief.

Sequence-specific DNA-binding proteins are components of a nuclear matrix-attachment site.

G S Stein, J L Stein, J B Lian, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Modifications in molecular mechanisms associated with control of cell cycle regulated human histone gene expression during differentiation

G. Stein, J. Lian, K. Wright, 1989, Cell Biophysics.

In vivo occupancy of histone gene proximal promoter elements reflects gene copy number‐dependent titratable transactivation factors and cross‐species compatibility of regulatory sequences

G. Stein, K. Wright, A. V. van Wijnen, 1995, Journal of cellular biochemistry.

Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D.

J. Lian, M. Kennedy, K. Wright, 1990, Science.

Functional and Structural Characterization of a Human H4 Histone Gene Promoter: a Thesis

K. Wright, 1990 .

Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter

S. Beck, J. Trowsdale, K. Wright, 1995, The Journal of experimental medicine.

Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice.

H. Ruffner, K. Wright, J. Ting, 1996, Immunity.

CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model

K. Wright, J. Ting, M. Linhoff, 1997, Molecular and cellular biology.

Histone Deacetylase Inhibitor LAQ824 Augments Inflammatory Responses in Macrophages through Transcriptional Regulation of IL-10

K. Bhalla, K. Wright, E. Seto, 2011, The Journal of Immunology.

MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-γ

K. Wright, Frederick L. Flynt, S. C. Bolick, 2007 .

MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.

K. Wright, Frederick L. Flynt, S. C. Bolick, 2007, Molecular immunology.

Positive Regulatory Domain I Binding Factor 1 Silences Class II Transactivator Expression in Multiple Myeloma Cells*

K. Wright, G. Wright, I. Győry, 2001, The Journal of Biological Chemistry.

Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers.

K. Wright, J. Pinilla-Ibarz, E. Sotomayor, 2009, Leukemia research.

JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations

Richard Z. Liu, Yuan Ren, Jie Wu, 2013, Scientific Reports.

Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits

K. Wright, J. Ting, A. Baldwin, 1994, Molecular and cellular biology.

The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance

P. Atadja, K. Bhalla, K. Wright, 2009, Nature Immunology.

Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a.

K. Wright, W. Dalton, L. Moscinski, 2010, Blood.

Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.

Kai Fu, Xiaohong Zhao, Tint Lwin, 2012, Cancer cell.

Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms

K. Wright, Vasundhara Sharma, G. Reuther, 2020, Frontiers in Immunology.

Epigenetic regulation of MHC-II and CIITA genes.

K. Wright, J. Ting, 2006, Trends in immunology.

Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines1

K. Wright, E. Seto, G. Fejer, 2003, The Journal of Immunology.

Lines 1 Transcription Repressor in Myeloma Cell Positive Regulatory Domain I Binding Factor Identification of a Functionally Impaired

K. Wright, E. Seto, G. Fejer, 2003 .

Major Histocompatibility Complex Class II-associated Invariant Chain Gene Expression Is Up-regulated by Cooperative Interactions of Sp1 and NF-Y (*)

K. Wright, J. Ting, B. Vilen, 1995, The Journal of Biological Chemistry.

MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output

T. Jenuwein, Zhi-Min Yuan, Jiandong Chen, 2010, The EMBO journal.

MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output

T. Jenuwein, Zhi-Min Yuan, Jiandong Chen, 2010, The EMBO journal.

Critical Role of the Tumor Suppressor Tuberous Sclerosis Complex 1 in Dendritic Cell Activation of CD4 T Cells by Promoting MHC Class II Expression via IRF4 and CIITA

K. Wright, G. Wright, T. F. O’Brien, 2013, The Journal of Immunology.

Multiple mechanisms regulate the proliferation-specific histone gene transcription factor HiNF-D in normal human diploid fibroblasts.

G. Stein, K. Wright, A. V. van Wijnen, 1992, Biochemistry.

How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene

G. Stark, K. Wright, J. Ting, 2000, The EMBO journal.

Regulation of the human transforming growth factor β type II receptor gene promoter by novel Sp1 sites

K. Wright, R. Jennings, M. Alsarraj, 2001, Oncogene.

HDAC11 Deficiency or Inhibition Disrupts Oncogene-Induced Stress Hematopoiesis in Myeloproliferative Neoplasms.

R. Levine, A. Verma, K. Wright, 2019, Blood.

Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.

G. Stark, J. M. Boss, K. Wright, 1994, Immunity.

Selective expression of the transcription elongation factor ELL3 in B cells prior to ELL2 drives proliferation and survival

K. Wright, P. Murray, Brook S. Nepon-Sixt, 2017, Molecular immunology.

Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1.

Ya-Li Yao, K. Wright, E. Seto, 2003, Genes & development.

Loss of Interferon-γ Inducibility of TAP1 and LMP2 in a Renal Cell Carcinoma Cell Line

K. Wright, N. Ghosh, S. Dovhey, 2000 .

Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements.

J. Yates, J. Yates, K. Wright, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas

K. Wright, P. Murray, M. Rowe, 2012, Pathogens.

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.

K. Wright, C. Woodman, P. Murray, 2011, Blood.

Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) Type IV promoter by interferon regulatory factors 1 and 2

K. Wright, D. Ghosh, G. Blanck, 1999, Oncogene.

Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.

K. Wright, J. Hudson, S. C. Bolick, 2007, Molecular immunology.

Positive Regulatory Domain I (PRDM1) and IRF8/PU.1 Counter-regulate MHC Class II Transactivator (CIITA) Expression during Dendritic Cell Maturation*

Sheng Wei, P. Tailor, K. Ozato, 2011, The Journal of Biological Chemistry.

Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.

K. Wright, N. Ghosh, S. Dovhey, 2000, Cancer research.

PU.1 Regulates Positive Regulatory Domain I-Binding Factor 1/Blimp-1 Transcription in Lymphoma Cells1

K. Wright, S. Desai, M. Maurin, 2009, The Journal of Immunology.

Identification of the Ankyrin Repeat Proteins ANKRA and RFXANK as Novel Partners of Class IIa Histone Deacetylases*

K. Wright, Hongwei Li, Xiang-Jiao Yang, 2005, Journal of Biological Chemistry.

Regulation of Inosine-5′-monophosphate Dehydrogenase Type II Gene Expression in Human T Cells

K. Wright, B. Mitchell, J. Ting, 1997, The Journal of Biological Chemistry.

GTP-dependent Recruitment of CIITA to the Class II Major Histocompatibility Complex Promoter*

K. Wright, N. Bewry, J. Harton, 2007, Journal of Biological Chemistry.

Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.

K. Wright, S. C. Bolick, J. Piskurich, 2006, Molecular immunology.

Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function.

K. Wright, G. Wright, B. Shah, 2020, Biochemical and biophysical research communications.

Involvement of the cell cycle-regulated nuclear factor HiNF-D in cell growth control of a human H4 histone gene during hepatic development in transgenic mice.

R. Jaenisch, G. Stein, J. Lian, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma

J. Cleveland, D. Gilvary, Sheng Wei, 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas

W. Tam, K. Wright, J. Tao, 2011, Leukemia.

Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma

H. Dai, A. Silva, O. Hampton, 2021, JCI insight.

PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL

I. Lossos, K. Wright, Xiaoyu Jiang, 2011, The FEBS journal.

The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression.

G. Li, K. Wright, J. Ting, 1997, Journal of Immunology.

Human major histocompatibility complex class II-associated invariant chain gene promoter. Functional analysis and in vivo protein/DNA interactions of constitutive and IFN-gamma-induced expression.

K. Wright, J. Ting, A. Brown, 1993, The Journal of biological chemistry.

Regulation and Specificity of MHC2TA Promoter Usage in Human Primary T Lymphocytes and Cell Line1

A. Wong, K. Wright, J. Ting, 2002, The Journal of Immunology.

CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies.

D. Gilvary, Sheng Wei, K. Wright, 2023, iScience.

In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.

K. Wright, J. Ting, 1992, Proceedings of the National Academy of Sciences of the United States of America.

The human H1 histone gene FNC16 is functionally expressed in proliferating HeLa S3 cells and is down-regulated during terminal differentiation in HL60 cells.

G. Stein, J. Lian, K. Wright, 1988, Journal of Biological Chemistry.

Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes

K. Wright, E. Padron, A. List, 2019, International journal of molecular sciences.

Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas

X. Zhang, K. Wright, G. Wright, 2012, Oncogene.

1-1-2012 Coordinated Silencing of MYC-Mediated miR-29 by HDAC 3 and EZH 2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas

K. Fu, K. Bhalla, S. Chen‐Kiang, 2013 .

Protein interactions at Sp1-like sites in the TGF alpha promoter as visualized by in vivo genomic footprinting.

K. Wright, J. Azizkhan, J. Ting, 1994, Oncogene.